A sentinel lymph node biopsy (SLNB) is a procedure in which the sentinel lymph node is identified, removed, and examined to determine whether cancer cells are present. It is used in people who have already been diagnosed with cancer. A negative SLNB result suggests that cancer has not yet spread to nearby lymph nodes or other organs.
Dec 12, · December 12, To help doctors give their patients the best possible care, the American Society of Clinical Oncology (ASCO) provides recommendations on sentinel lymph node biopsy for people with early-stage breast cancer. This guide for patients is based on the most recent recommendations.
The sentinel lymph node biopsy is a safe, accurate operation for the initial staging of breast cancer. Over the last decade, there has been increasing literature supporting its use, and it is now considered a standard of care for the initial evaluation of metastatic spread to the axillary lymph node chain.
Sep 13, · Sentinel lymph node biopsy is the most common and least invasive way, but in some cases a more extensive axillary lymph node dissection might be needed. Lymph node surgery is often done as part of the main surgery to remove the breast cancer, but in some cases it might be done as a separate operation. Sentinel lymph node biopsy (SLNB)Last Revised: September 13,